EFFECTS OF 1,2-DIMETHYL-3-HYDROXYPYRID-4-ONE (L1) ON CELL-PROLIFERATION

被引：0
|
作者：
ELORRIAGA, R [1 ]
FRAGA, PM [1 ]
NAVES, ML [1 ]
CANNATA, JB [1 ]
机构：
[1] HOSP CENT ASTURIAS,BONE & MINERAL RES UNIT,OVIEDO,SPAIN
来源：
KIDNEY INTERNATIONAL | 1994年 / 46卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：587 / 587
页数：1
相关论文
共 50 条
  • [11] A COMPARISON OF THE IRON-CLEARING PROPERTIES OF 1,2-DIMETHYL-3-HYDROXYPYRID-4-ONE, 1,2-DIETHYL-3-HYDROXYPYRID-4-ONE, AND DEFEROXAMINE
    BERGERON, RJ
    STREIFF, RR
    WIEGAND, J
    LUCHETTA, G
    CREARY, EA
    PETER, HH
    BLOOD, 1992, 79 (07) : 1882 - 1890
  • [12] Interaction between 1,2-dimethyl-3-hydroxypyrid-4-one and europium(III)
    Hadjiloizou, P.
    Pashalidis, I.
    JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY, 2007, 273 (03) : 553 - 556
  • [13] METHODOLOGICAL ISSUES IN STUDYING THE EFFECT OF THE NEW ORAL CHELATOR 1,2-DIMETHYL-3-HYDROXYPYRID-4-ONE(L1) ON ABSORPTION OF IRON
    BENTUR, Y
    KLEIN, J
    LEVY, M
    OLIVIERI, N
    MCGUIGAN, M
    KOREN, G
    VETERINARY AND HUMAN TOXICOLOGY, 1990, 32 (02) : 159 - 162
  • [14] STUDIES OF THE ORAL CHELATOR 1,2-DIMETHYL-3-HYDROXYPYRID-4-ONE IN THALASSEMIA PATIENTS
    OLIVIERI, NF
    KOREN, G
    STLOUIS, P
    FREEDMAN, MH
    MCCLELLAND, RA
    TEMPLETON, DM
    SEMINARS IN HEMATOLOGY, 1990, 27 (02) : 101 - 104
  • [15] CORRELATION OF IRON EXCHANGE BETWEEN THE ORAL IRON CHELATOR 1,2-DIMETHYL-3-HYDROXYPYRID-4-ONE (L1) AND TRANSFERRIN AND POSSIBLE ANTIANEMIC EFFECTS OF L1 IN RHEUMATOID-ARTHRITIS
    VREUGDENHIL, G
    SWAAK, AJG
    DEJEUJASPARS, C
    VANEIJK, HG
    ANNALS OF THE RHEUMATIC DISEASES, 1990, 49 (11) : 956 - 957
  • [16] ORAL 1,2-DIMETHYL-3-HYDROXYPYRID-4-ONE FOR THE TREATMENT OF TRANSFUSIONAL IRON OVERLOAD
    KONTOGHIORGHES, GJ
    SHEPPARD, L
    ALDOURI, MA
    WONKE, B
    BARR, J
    HOFFBRAND, AV
    BRITISH JOURNAL OF HAEMATOLOGY, 1988, 68 (04) : 508 - 508
  • [17] ADVERSE RHEUMATOLOGIC EFFECTS OF DIMETHYL-3-HYDROXYPYRID-4-ONE (L1)
    BERKOVITCH, M
    LAXER, R
    MATSUI, D
    FRITZLER, M
    HEDDEN, D
    KOREN, G
    KLEIN, J
    PRITZKER, K
    OLIVIERI, N
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1993, 53 (02) : 149 - 149
  • [18] COMPARISON OF THE PHARMACOKINETICS OF 1,2-DIMETHYL-3-HYDROXYPYRID-4-ONE (L1) IN HEALTHY-VOLUNTEERS, WITH AND WITHOUT COADMINISTRATION OF FERROUS SULFATE, TO THALASSEMIA PATIENTS
    STOBIE, S
    TYBERG, J
    MATSUI, D
    FERNANDES, D
    KLEIN, J
    OLIVIERI, N
    BENTUR, Y
    KOREN, G
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 1993, 31 (12) : 602 - 605
  • [19] PHARMACOKINETIC STUDIES IN HUMANS WITH THE ORAL IRON CHELATOR 1,2-DIMETHYL-3-HYDROXYPYRID-4-ONE
    KONTOGHIORGHES, GJ
    GODDARD, JG
    BARTLETT, AN
    SHEPPARD, L
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1990, 48 (03) : 255 - 261
  • [20] 1,2-DIMETHYL-3-HYDROXYPYRID-4-ONE, AN ORALLY ACTIVE CHELATOR FOR TREATMENT OF IRON OVERLOAD
    KONTOGHIORGHES, GJ
    ALDOURI, MA
    SHEPPARD, L
    HOFFBRAND, AV
    LANCET, 1987, 1 (8545): : 1294 - 1295
12345